Table II.
Passive hip joint movements before therapy and after 4 months of treatment with standardized rose-hip powder (SRHP) and placebo.
| Type of Movement | Baseline, deg∗ | Restriction of Movement, deg | At 4 Months of Therapy, deg∗ | Improvement, % |
|---|---|---|---|---|
| Flexion | ||||
| SRHP | 116.00 (13.92) | 9.0 | 119.37 (14.09)†‡ | 40.0 |
| Placebo | 111.05 (12.76) | 13.9 | 112.38 (14.27) | 6.7 |
| External rotation | ||||
| SRHP | 26.40 (9.74) | 18.6 | 28.96 (8.84)§ | 17.1 |
| Placebo | 19.72 (11.56) | 25.3 | 22.50 (11.40) | 10.0 |
| Internal rotation | ||||
| SRHP | 28.80 (13.17) | 16.2 | 34.38 (13.41)∥ | 35.0 |
| Placebo | 28.68 (11.61) | 16.4 | 33.13 (12.09)¶ | 24.0 |
Values are expressed as mean (SD).
P=0.003 versus pretreatment.
P=0.033 versus placebo.
P=0.006 versus pretreatment.
P<0.001 versus pretreatment.
P=0.031 versus pretreatment.